Global OTC Drug Sales Market Report 2020

SKU ID :QYR-16621153 | Published Date: 29-Oct-2020 | No. of pages: 142
1 OTC Drug Market Overview 1.1 OTC Drug Product Scope 1.2 OTC Drug Segment by Type 1.2.1 Global OTC Drug Sales by Type (2020-2026) 1.2.2 Class A 1.2.3 Class B 1.3 OTC Drug Segment by Application 1.3.1 Global OTC Drug Sales Comparison by Application (2020-2026) 1.3.2 Hospital 1.3.3 Clinic 1.3.4 Household 1.4 OTC Drug Market Estimates and Forecasts (2015-2026) 1.4.1 Global OTC Drug Sales Growth Rate (2015-2026) 1.4.2 Global OTC Drug Revenue and Growth Rate (2015-2026) 1.4.3 Global OTC Drug Price Trends (2015-2026) 2 OTC Drug Estimate and Forecast by Region 2.1 Global OTC Drug Market Size by Region: 2015 VS 2020 VS 2026 2.2 Global OTC Drug Retrospective Market Scenario by Region (2015-2020) 2.2.1 Global OTC Drug Sales Market Share by Region (2015-2020) 2.2.2 Global OTC Drug Revenue Market Share by Region (2015-2020) 2.3 Global OTC Drug Market Estimates and Forecasts by Region (2021-2026) 2.3.1 Global OTC Drug Sales Estimates and Forecasts by Region (2021-2026) 2.3.2 Global OTC Drug Revenue Forecast by Region (2021-2026) 2.4 Geographic Market Analysis: Market Facts & Figures 2.4.1 United States OTC Drug Estimates and Projections (2015-2026) 2.4.2 Europe OTC Drug Estimates and Projections (2015-2026) 2.4.3 China OTC Drug Estimates and Projections (2015-2026) 2.4.4 Japan OTC Drug Estimates and Projections (2015-2026) 2.4.5 Southeast Asia OTC Drug Estimates and Projections (2015-2026) 2.4.6 India OTC Drug Estimates and Projections (2015-2026) 3 Global OTC Drug Competition Landscape by Players 3.1 Global Top OTC Drug Players by Sales (2015-2020) 3.2 Global Top OTC Drug Players by Revenue (2015-2020) 3.3 Global OTC Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in OTC Drug as of 2019) 3.4 Global OTC Drug Average Price by Company (2015-2020) 3.5 Manufacturers OTC Drug Manufacturing Sites, Area Served, Product Type 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3.7 Primary Interviews with Key OTC Drug Players (Opinion Leaders) 4 Global OTC Drug Market Size by Type 4.1 Global OTC Drug Historic Market Review by Type (2015-2020) 4.1.1 Global OTC Drug Sales Market Share by Type (2015-2020) 4.1.2 Global OTC Drug Revenue Market Share by Type (2015-2020) 4.1.3 Global OTC Drug Price by Type (2015-2020) 4.2 Global OTC Drug Market Estimates and Forecasts by Type (2021-2026) 4.2.1 Global OTC Drug Sales Forecast by Type (2021-2026) 4.2.2 Global OTC Drug Revenue Forecast by Type (2021-2026) 4.2.3 Global OTC Drug Price Forecast by Type (2021-2026) 5 Global OTC Drug Market Size by Application 5.1 Global OTC Drug Historic Market Review by Application (2015-2020) 5.1.1 Global OTC Drug Sales Market Share by Application (2015-2020) 5.1.2 Global OTC Drug Revenue Market Share by Application (2015-2020) 5.1.3 Global OTC Drug Price by Application (2015-2020) 5.2 Global OTC Drug Market Estimates and Forecasts by Application (2021-2026) 5.2.1 Global OTC Drug Sales Forecast by Application (2021-2026) 5.2.2 Global OTC Drug Revenue Forecast by Application (2021-2026) 5.2.3 Global OTC Drug Price Forecast by Application (2021-2026) 6 United States OTC Drug Market Facts & Figures 6.1 United States OTC Drug Sales Market Share by Company (2015-2020) 6.2 United States OTC Drug Sales Market Share by Type (2015-2020) 6.3 United States OTC Drug Sales Market Share by Application (2015-2020) 7 Europe OTC Drug Market Facts & Figures 7.1 Europe OTC Drug Sales Market Share by Company (2015-2020) 7.2 Europe OTC Drug Sales Market Share by Type (2015-2020) 7.3 Europe OTC Drug Sales Market Share by Application (2015-2020) 8 China OTC Drug Market Facts & Figures 8.1 China OTC Drug Sales Market Share by Company (2015-2020) 8.2 China OTC Drug Sales Market Share by Type (2015-2020) 8.3 China OTC Drug Sales Market Share by Application (2015-2020) 9 Japan OTC Drug Market Facts & Figures 9.1 Japan OTC Drug Sales Market Share by Company (3015-3030) 9.2 Japan OTC Drug Sales Market Share by Type (2015-2020) 9.3 Japan OTC Drug Sales Market Share by Application (2015-2020) 10 Southeast Asia OTC Drug Market Facts & Figures 10.1 Southeast Asia OTC Drug Sales Market Share by Company (2015-2020) 10.2 Southeast Asia OTC Drug Sales Market Share by Type (2015-2020) 10.3 Southeast Asia OTC Drug Sales Market Share by Application (2015-2020) 11 India OTC Drug Market Facts & Figures 11.1 India OTC Drug Sales Market Share by Company (2015-2020) 11.2 India OTC Drug Sales Market Share by Type (2015-2020) 11.3 India OTC Drug Sales Market Share by Application (2015-2020) 12 Company Profiles and Key Figures in OTC Drug Business 12.1 Bayer HealthCare 12.1.1 Bayer HealthCare Corporation Information 12.1.2 Bayer HealthCare Business Overview 12.1.3 Bayer HealthCare OTC Drug Sales, Revenue and Gross Margin (2015-2020) 12.1.4 Bayer HealthCare OTC Drug Products Offered 12.1.5 Bayer HealthCare Recent Development 12.2 GlaxoSmithKline (GSK) 12.2.1 GlaxoSmithKline (GSK) Corporation Information 12.2.2 GlaxoSmithKline (GSK) Business Overview 12.2.3 GlaxoSmithKline (GSK) OTC Drug Sales, Revenue and Gross Margin (2015-2020) 12.2.4 GlaxoSmithKline (GSK) OTC Drug Products Offered 12.2.5 GlaxoSmithKline (GSK) Recent Development 12.3 Johnson&Johnson 12.3.1 Johnson&Johnson Corporation Information 12.3.2 Johnson&Johnson Business Overview 12.3.3 Johnson&Johnson OTC Drug Sales, Revenue and Gross Margin (2015-2020) 12.3.4 Johnson&Johnson OTC Drug Products Offered 12.3.5 Johnson&Johnson Recent Development 12.4 Pfizer 12.4.1 Pfizer Corporation Information 12.4.2 Pfizer Business Overview 12.4.3 Pfizer OTC Drug Sales, Revenue and Gross Margin (2015-2020) 12.4.4 Pfizer OTC Drug Products Offered 12.4.5 Pfizer Recent Development 12.5 Sanofi 12.5.1 Sanofi Corporation Information 12.5.2 Sanofi Business Overview 12.5.3 Sanofi OTC Drug Sales, Revenue and Gross Margin (2015-2020) 12.5.4 Sanofi OTC Drug Products Offered 12.5.5 Sanofi Recent Development 12.6 AstraZeneca 12.6.1 AstraZeneca Corporation Information 12.6.2 AstraZeneca Business Overview 12.6.3 AstraZeneca OTC Drug Sales, Revenue and Gross Margin (2015-2020) 12.6.4 AstraZeneca OTC Drug Products Offered 12.6.5 AstraZeneca Recent Development 12.7 BioGaia 12.7.1 BioGaia Corporation Information 12.7.2 BioGaia Business Overview 12.7.3 BioGaia OTC Drug Sales, Revenue and Gross Margin (2015-2020) 12.7.4 BioGaia OTC Drug Products Offered 12.7.5 BioGaia Recent Development 12.8 Bristol Myers Squibb 12.8.1 Bristol Myers Squibb Corporation Information 12.8.2 Bristol Myers Squibb Business Overview 12.8.3 Bristol Myers Squibb OTC Drug Sales, Revenue and Gross Margin (2015-2020) 12.8.4 Bristol Myers Squibb OTC Drug Products Offered 12.8.5 Bristol Myers Squibb Recent Development 12.9 Bukwang Pharmaceutica 12.9.1 Bukwang Pharmaceutica Corporation Information 12.9.2 Bukwang Pharmaceutica Business Overview 12.9.3 Bukwang Pharmaceutica OTC Drug Sales, Revenue and Gross Margin (2015-2020) 12.9.4 Bukwang Pharmaceutica OTC Drug Products Offered 12.9.5 Bukwang Pharmaceutica Recent Development 12.10 Chr. Hansen 12.10.1 Chr. Hansen Corporation Information 12.10.2 Chr. Hansen Business Overview 12.10.3 Chr. Hansen OTC Drug Sales, Revenue and Gross Margin (2015-2020) 12.10.4 Chr. Hansen OTC Drug Products Offered 12.10.5 Chr. Hansen Recent Development 12.11 Cipla 12.11.1 Cipla Corporation Information 12.11.2 Cipla Business Overview 12.11.3 Cipla OTC Drug Sales, Revenue and Gross Margin (2015-2020) 12.11.4 Cipla OTC Drug Products Offered 12.11.5 Cipla Recent Development 12.12 CoLucid 12.12.1 CoLucid Corporation Information 12.12.2 CoLucid Business Overview 12.12.3 CoLucid OTC Drug Sales, Revenue and Gross Margin (2015-2020) 12.12.4 CoLucid OTC Drug Products Offered 12.12.5 CoLucid Recent Development 12.13 Daiichi Sankyo 12.13.1 Daiichi Sankyo Corporation Information 12.13.2 Daiichi Sankyo Business Overview 12.13.3 Daiichi Sankyo OTC Drug Sales, Revenue and Gross Margin (2015-2020) 12.13.4 Daiichi Sankyo OTC Drug Products Offered 12.13.5 Daiichi Sankyo Recent Development 12.14 Friggs 12.14.1 Friggs Corporation Information 12.14.2 Friggs Business Overview 12.14.3 Friggs OTC Drug Sales, Revenue and Gross Margin (2015-2020) 12.14.4 Friggs OTC Drug Products Offered 12.14.5 Friggs Recent Development 12.15 DSM 12.15.1 DSM Corporation Information 12.15.2 DSM Business Overview 12.15.3 DSM OTC Drug Sales, Revenue and Gross Margin (2015-2020) 12.15.4 DSM OTC Drug Products Offered 12.15.5 DSM Recent Development 12.16 Eisai 12.16.1 Eisai Corporation Information 12.16.2 Eisai Business Overview 12.16.3 Eisai OTC Drug Sales, Revenue and Gross Margin (2015-2020) 12.16.4 Eisai OTC Drug Products Offered 12.16.5 Eisai Recent Development 12.17 Eli Lilly 12.17.1 Eli Lilly Corporation Information 12.17.2 Eli Lilly Business Overview 12.17.3 Eli Lilly OTC Drug Sales, Revenue and Gross Margin (2015-2020) 12.17.4 Eli Lilly OTC Drug Products Offered 12.17.5 Eli Lilly Recent Development 12.18 Herbalife 12.18.1 Herbalife Corporation Information 12.18.2 Herbalife Business Overview 12.18.3 Herbalife OTC Drug Sales, Revenue and Gross Margin (2015-2020) 12.18.4 Herbalife OTC Drug Products Offered 12.18.5 Herbalife Recent Development 12.19 Euradite 12.19.1 Euradite Corporation Information 12.19.2 Euradite Business Overview 12.19.3 Euradite OTC Drug Sales, Revenue and Gross Margin (2015-2020) 12.19.4 Euradite OTC Drug Products Offered 12.19.5 Euradite Recent Development 13 OTC Drug Manufacturing Cost Analysis 13.1 OTC Drug Key Raw Materials Analysis 13.1.1 Key Raw Materials 13.1.2 Key Raw Materials Price Trend 13.1.3 Key Suppliers of Raw Materials 13.2 Proportion of Manufacturing Cost Structure 13.3 Manufacturing Process Analysis of OTC Drug 13.4 OTC Drug Industrial Chain Analysis 14 Marketing Channel, Distributors and Customers 14.1 Marketing Channel 14.2 OTC Drug Distributors List 14.3 OTC Drug Customers 15 Market Dynamics 15.1 OTC Drug Market Trends 15.2 OTC Drug Opportunities and Drivers 15.3 OTC Drug Market Challenges 15.4 OTC Drug Market Restraints 15.5 Porter's Five Forces Analysis 16 Research Findings and Conclusion 17 Appendix 17.1 Research Methodology 17.1.1 Methodology/Research Approach 17.1.2 Data Source 17.2 Author List 17.3 Disclaimer
List of Tables Table 1. Global OTC Drug Sales (MT) Growth Rate by Type (2020-2026) (US$ Million) Table 2. Global OTC Drug Sales (MT) Comparison by Application (2020-2026) (US$ Million) Table 3. Global Market OTC Drug Market Size (US$ Million) by Region:2015 VS 2020 &2026 Table 4. Global OTC Drug Sales (MT) by Region (2015-2020) Table 5. Global OTC Drug Sales Market Share by Region (2015-2020) Table 6. Global OTC Drug Revenue (US$ Million) Market Share by Region (2015-2020)) Table 7. Global OTC Drug Revenue Share by Region (2015-2020) Table 8. Global OTC Drug Sales (MT) Forecast by Region (2021-2026) Table 9. Global OTC Drug Sales Market Share Forecast by Region (2021-2026) Table 10. Global OTC Drug Revenue (US$ Million) Forecast by Region (2021-2026) Table 11. Global OTC Drug Revenue Share Forecast by Region (2021-2026) Table 12. Global OTC Drug (MT) of Key Companies (2015-2020) Table 13. Global OTC Drug Sales Share by Company (2015-2020) Table 14. Global OTC Drug Revenue (US$ Million) by Company (2015-2020) Table 15. Global OTC Drug Revenue Share by Company (2015-2020) Table 16. Global OTC Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in OTC Drug as of 2019) Table 17. Global OTC Drug Average Price (USD/MT) of Key Company (2015-2020) Table 18. Manufacturers OTC Drug Manufacturing Sites and Area Served Table 19. Manufacturers OTC Drug Product Type Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans Table 21. Main Points Interviewed from Key OTC Drug Players Table 22. Global OTC Drug Sales (MT) by Type (2015-2020) Table 23. Global OTC Drug Sales Share by Type (2015-2020) Table 24. Global OTC Drug Revenue (US$ Million) Market Share by Type (2015-2020) Table 25. Global OTC Drug Price (MT) by Type (2015-2020) Table 26. Global OTC Drug Sales Share by Type (2021-2026) Table 27. Global OTC Drug Revenue (US$ Million) Market Share by Type (2021-2026) Table 28. Global OTC Drug Revenue Share by Type (2021-2026) Table 29. Global OTC Drug Price (MT) by Type (2021-2026) Table 30. Global OTC Drug Sales (MT) by Application (2015-2020) Table 31. Global OTC Drug Sales Share by Application (2015-2020) Table 32. Global OTC Drug Revenue (US$ Million) Market Share by Application (2015-2020) Table 33. Global OTC Drug Price (MT) by Application (2015-2020) Table 34. Global OTC Drug Sales (MT) by Application (2021-2026) Table 35. Global OTC Drug Sales Share by Application (2021-2026) Table 36. Global OTC Drug Revenue (US$ Million) Market Share by Application (2021-2026) Table 37. Global OTC Drug Revenue Share by Application (2021-2026) Table 38. Global OTC Drug Price (MT) by Application (2021-2026) Table 39. United States OTC Drug Sales (MT) by Company (2015-2020) Table 40. United States OTC Drug Sales Market Share by Company (2015-2020) Table 41. United States OTC Drug Sales (MT) by Type (2015-2020) Table 42. United States OTC Drug Sales Market Share by Type (2015-2020) Table 43. United States OTC Drug Sales (MT) by Application (2015-2020) Table 44. United States OTC Drug Sales Market Share by Application (2015-2020) Table 45. Europe OTC Drug Sales (MT) by Company (2015-2020) Table 46. Europe OTC Drug Sales Market Share by Company (2015-2020) Table 47. Europe OTC Drug Sales (MT) by Type (2015-2020) Table 48. Europe OTC Drug Sales Market Share by Type (2015-2020) Table 49. Europe OTC Drug Sales (MT) by Application (2015-2020) Table 50. Europe OTC Drug Sales Market Share by Type (2015-2020) Table 51. China OTC Drug Sales (MT) by Company (2015-2020) Table 52. China OTC Drug Sales Market Share by Company (2015-2020) Table 53. China OTC Drug Sales (MT) by Type (2015-2020) Table 54. China OTC Drug Sales Market Share by Type (2015-2020) Table 55. China OTC Drug Sales (MT) by Application (2015-2020) Table 56. China OTC Drug Sales Market Share by Application (2015-2020) Table 57. Japan OTC Drug Sales (MT) by Company (2015-2020) Table 58. Japan OTC Drug Sales Market Share by Company (2015-2020) Table 59. Japan OTC Drug Sales (MT) by Type (2015-2020) Table 60. Japan OTC Drug Sales Market Share by Type (2015-2020) Table 61. Japan OTC Drug Sales (MT) by Application (2015-2020) Table 62. Japan OTC Drug Sales Market Share by Application (2015-2020) Table 63. Southeast Asia OTC Drug Sales (MT) by Company (2015-2020) Table 64. Southeast Asia OTC Drug Sales Market Share by Company (2015-2020) Table 65. Southeast Asia OTC Drug Sales (MT) by Type (2015-2020) Table 66. Southeast Asia OTC Drug Sales Market Share by Type (2015-2020) Table 67. Southeast Asia OTC Drug Sales (MT) by Type (2015-2020) Table 68. Southeast Asia OTC Drug Sales Market Share by Application (2015-2020) Table 69. India OTC Drug Sales (MT) by Company (2015-2020) Table 70. India OTC Drug Sales Market Share by Company (2015-2020) Table 71. India OTC Drug Sales (MT) by Type (2015-2020) Table 72. India OTC Drug Sales Market Share by Type (2015-2020) Table 73. India OTC Drug Sales (MT) by Application (2015-2020) Table 74. India OTC Drug Sales Market Share by Application (2015-2020) Table 75. Bayer HealthCare Corporation Information Table 76. Bayer HealthCare Description and Business Overview Table 77. Bayer HealthCare OTC Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020) Table 78. Bayer HealthCare OTC Drug Product Table 79. Bayer HealthCare Recent Development Table 80. GlaxoSmithKline (GSK) Corporation Information Table 81. GlaxoSmithKline (GSK) Description and Business Overview Table 82. GlaxoSmithKline (GSK) OTC Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020) Table 83. GlaxoSmithKline (GSK) OTC Drug Product Table 84. GlaxoSmithKline (GSK) Recent Development Table 85. Johnson&Johnson Corporation Information Table 86. Johnson&Johnson Description and Business Overview Table 87. Johnson&Johnson OTC Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020) Table 88. Johnson&Johnson OTC Drug Product Table 89. Johnson&Johnson Recent Development Table 90. Pfizer Corporation Information Table 91. Pfizer Description and Business Overview Table 92. Pfizer OTC Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020) Table 93. Pfizer OTC Drug Product Table 94. Pfizer Recent Development Table 95. Sanofi Corporation Information Table 96. Sanofi Description and Business Overview Table 97. Sanofi OTC Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020) Table 98. Sanofi OTC Drug Product Table 99. Sanofi Recent Development Table 100. AstraZeneca Corporation Information Table 101. AstraZeneca Description and Business Overview Table 102. AstraZeneca OTC Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020) Table 103. AstraZeneca OTC Drug Product Table 104. AstraZeneca Recent Development Table 105. BioGaia Corporation Information Table 106. BioGaia Description and Business Overview Table 107. BioGaia OTC Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020) Table 108. BioGaia OTC Drug Product Table 109. BioGaia Recent Development Table 110. Bristol Myers Squibb Corporation Information Table 111. Bristol Myers Squibb OTC Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020) Table 112. Bristol Myers Squibb Description and Business Overview Table 113. Bristol Myers Squibb OTC Drug Product Table 114. Bristol Myers Squibb Recent Development Table 115. Bukwang Pharmaceutica Corporation Information Table 116. Bukwang Pharmaceutica OTC Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020) Table 117. Bukwang Pharmaceutica Description and Business Overview Table 118. Bukwang Pharmaceutica OTC Drug Product Table 119. Bukwang Pharmaceutica Recent Development Table 120. Chr. Hansen Corporation Information Table 121. Chr. Hansen Description and Business Overview Table 122. Chr. Hansen OTC Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020) Table 123. Chr. Hansen OTC Drug Product Table 124. Chr. Hansen Recent Development Table 125. Cipla Corporation Information Table 126. Cipla Description and Business Overview Table 127. Cipla OTC Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020) Table 128. Cipla OTC Drug Product Table 129. Cipla Recent Development Table 130. CoLucid Corporation Information Table 131. CoLucid Description and Business Overview Table 132. CoLucid OTC Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020) Table 133. CoLucid OTC Drug Product Table 134. CoLucid Recent Development Table 135. Daiichi Sankyo Corporation Information Table 136. Daiichi Sankyo Description and Business Overview Table 137. Daiichi Sankyo OTC Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020) Table 138. Daiichi Sankyo OTC Drug Product Table 139. Daiichi Sankyo Recent Development Table 140. Friggs Corporation Information Table 141. Friggs Description and Business Overview Table 142. Friggs OTC Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020) Table 143. Friggs OTC Drug Product Table 144. Friggs Recent Development Table 145. DSM Corporation Information Table 146. DSM Description and Business Overview Table 147. DSM OTC Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020) Table 148. DSM OTC Drug Product Table 149. DSM Recent Development Table 150. Eisai Corporation Information Table 151. Eisai Description and Business Overview Table 152. Eisai OTC Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020) Table 153. Eisai OTC Drug Product Table 154. Eisai Recent Development Table 155. Eli Lilly Corporation Information Table 156. Eli Lilly Description and Business Overview Table 157. Eli Lilly OTC Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020) Table 158. Eli Lilly OTC Drug Product Table 159. Eli Lilly Recent Development Table 160. Herbalife Corporation Information Table 161. Herbalife Description and Business Overview Table 162. Herbalife OTC Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020) Table 163. Herbalife OTC Drug Product Table 164. Herbalife Recent Development Table 165. Euradite Corporation Information Table 166. Euradite Description and Business Overview Table 167. Euradite OTC Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020) Table 168. Euradite OTC Drug Product Table 169. Euradite Recent Development Table 170. Production Base and Market Concentration Rate of Raw Material Table 171. Key Suppliers of Raw Materials Table 172. OTC Drug Distributors List Table 173. OTC Drug Customers List Table 174. OTC Drug Market Key Trends Table 175. OTC Drug Key Opportunities and Drivers Table 176. OTC Drug Market Challenges Table 177. Research Programs/Design for This Report Table 178. Key Data Information from Secondary Sources Table 179. Key Data Information from Primary Sources List of Figures Figure 1. OTC Drug Product Picture Figure 2. Global OTC Drug Sales Market Share by Type in 2020 & 2026 Figure 3. Type I Product Picture Figure 4. Type II Product Picture Figure 5. Global OTC Drug Market Share by Application in 2020 & 2026 Figure 6. Hospital Examples Figure 7. Clinic Examples Figure 8. Household Examples Figure 9. Global OTC Drug Sales (MT) Growth Rate (2015-2026) Figure 10. Global OTC Drug Revenue (US$ Million) Growth Rate (2015-2026) Figure 11. Global OTC Drug Price Trends Growth Rate (2015-2026) (USD/MT) Figure 12. Global OTC Drug Revenue Market Share by Region: 2015 VS 2020 Figure 13. Global OTC Drug Revenue Market Share by Region: 2021 VS 2026 Figure 14. United States OTC Drug Revenue (Million USD) Growth Rate (2015-2026) Figure 15. United States OTC Drug Sales (MT) Growth Rate (2015-2026) Figure 16. Europe OTC Drug Revenue (Million USD) Growth Rate (2015-2026) Figure 17. Europe OTC Drug Sales (Million USD) Growth Rate (2015-2026) Figure 18. China OTC Drug Revenue (Million USD) Growth Rate (2015-2026) Figure 19. China OTC Drug Sales (Million USD) and Growth Rate (2015-2026) Figure 20. Japan OTC Drug Revenue (Million USD) Growth Rate (2015-2026) Figure 21. Japan OTC Drug Sales (Million USD) Growth Rate (2015-2026) Figure 22. Southeast Asia OTC Drug Revenue (Million USD) Growth Rate (2015-2026) Figure 23. Southeast Asia OTC Drug Sales (Million USD) Growth Rate (2015-2026) Figure 24. India OTC Drug Revenue (Million USD) Growth Rate (2015-2026) Figure 25. India OTC Drug Sales (Million USD) Growth Rate (2015-2026) Figure 26. Global 5 Largest OTC Drug Players Market Share by Revenue in OTC Drug 2015 & 2019 Figure 27. OTC Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 28. Global OTC Drug Revenue Share by Type (2015-2020) Figure 29. Global OTC Drug Revenue Growth Rate by Type in 2015 & 2019 Figure 30. Global OTC Drug Revenue Share by Application (2015-2020) Figure 31. Global OTC Drug Revenue Growth Rate by Application in 2015 & 2019 Figure 32. United States OTC Drug Sales Market Share by Type in 2019 Figure 33. United States OTC Drug Sales Market Share by Type in 2019 Figure 34. Europe OTC Drug Sales Market Share by Company in 2019 Figure 35. Europe OTC Drug Sales Market Share by Type in 2019 Figure 36. Europe OTC Drug Sales Market Share by Application in 2019 Figure 37. China OTC Drug Sales Market Share by Company in 2019 Figure 38. China OTC Drug Sales Market Share by Type in 2019 Figure 39. China OTC Drug Sales Market Share by Application in 2019 Figure 40. Japan OTC Drug Sales Market Share by Company in 2019 Figure 41. Japan OTC Drug Sales Market Share by Type in 2019 Figure 42. Japan OTC Drug Sales Market Share by Application in 2019 Figure 43. Southeast Asia OTC Drug Sales Market Share by Company in 2019 Figure 44. Southeast Asia OTC Drug Sales Market Share by Type in 2019 Figure 45. Southeast Asia OTC Drug Sales Market Share by Application in 2019 Figure 46. India OTC Drug Sales Market Share by Company in 2019 Figure 47. India OTC Drug Sales Market Share by Type in 2019 Figure 48. India OTC Drug Sales Market Share by Application in 2019 Figure 49. Key Raw Materials Price Trend Figure 50. Manufacturing Cost Structure of OTC Drug Figure 51. Manufacturing Process Analysis of OTC Drug Figure 52. OTC Drug Industrial Chain Analysis Figure 53. Channels of Distribution Figure 54. Distributors Profiles Figure 55. Porter's Five Forces Analysis Figure 56. Bottom-up and Top-down Approaches for This Report Figure 57. Data Triangulation Figure 58. Key Executives Interviewed
Bayer HealthCare GlaxoSmithKline (GSK) Johnson&Johnson Pfizer Sanofi AstraZeneca BioGaia Bristol Myers Squibb Bukwang Pharmaceutica Chr. Hansen Cipla CoLucid Daiichi Sankyo Friggs DSM Eisai Eli Lilly Herbalife Euradite
  • PRICE
  • $4000
    $8000
    $6000

Our Clients